Wuhan Dazhong Dental Medical Co., Ltd. (HKG:2651)
Hong Kong · Delayed Price · Currency is HKD 29.08
+2.88 (10.99%)
Sep 2, 2026, 3:42 PM HKT
HKG:2651 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2016 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '16 Dec 31, 2016 |
| 1,325 | 509 | - | - | - | - | |
Market Cap Growth | 82.56% | - | - | - | - | - |
Enterprise Value | 1,186 | 585 | - | - | - | - |
Last Close Price | 26.20 | 9.67 | - | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2016 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '16 Dec 31, 2016 |
PE Ratio | 43.78 | 16.22 | - | - | - | - |
PS Ratio | 3.13 | 1.23 | - | - | - | - |
PB Ratio | 3.29 | 1.22 | - | - | - | - |
P/TBV Ratio | 4.91 | 1.79 | - | - | - | - |
P/FCF Ratio | 16.08 | 5.66 | - | - | - | - |
P/OCF Ratio | 14.12 | 4.86 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2016 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '16 Dec 31, 2016 |
EV/Sales Ratio | 2.80 | 1.42 | - | - | - | - |
EV/EBITDA Ratio | 9.63 | 6.55 | - | - | - | - |
EV/EBIT Ratio | 17.13 | 8.85 | - | - | - | - |
EV/FCF Ratio | 14.39 | 6.51 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2016 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '16 Dec 31, 2016 |
Debt / Equity Ratio | 0.20 | 0.20 | 0.71 | 0.59 | 0.79 | - |
Debt / EBITDA Ratio | 0.64 | 0.67 | 0.89 | 0.70 | 0.87 | - |
Debt / FCF Ratio | 0.95 | 0.93 | 1.47 | 0.78 | 1.06 | - |
Net Debt / Equity Ratio | -0.49 | -0.56 | 0.11 | -0.73 | -0.47 | -0.09 |
Net Debt / EBITDA Ratio | -2.18 | -2.63 | 0.20 | -1.17 | -0.73 | -0.26 |
Net Debt / FCF Ratio | -2.39 | -2.61 | 0.23 | -0.96 | -0.62 | 0.71 |
Asset Turnover | 0.88 | 0.83 | 0.94 | 0.93 | - | 1.53 |
Inventory Turnover | 53.16 | 76.30 | 54.41 | 46.23 | - | 20.33 |
Quick Ratio | 2.84 | 3.26 | 0.77 | 0.96 | 1.49 | 1.11 |
Current Ratio | 3.24 | 3.35 | 0.90 | 1.00 | 1.58 | 1.71 |
Return on Equity (ROE) | 16.80% | 18.98% | 37.86% | 42.84% | - | 25.12% |
Return on Assets (ROA) | 9.02% | 8.32% | 10.12% | 11.07% | - | 16.44% |
Return on Invested Capital (ROIC) | 29.48% | 30.56% | 55.71% | 117.85% | 97.28% | 28.27% |
Return on Capital Employed (ROCE) | 15.20% | 14.00% | 29.00% | 34.70% | 19.90% | 27.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2016 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '16 Dec 31, 2016 |
Earnings Yield | 2.35% | 6.17% | - | - | - | - |
FCF Yield | 6.22% | 17.68% | - | - | - | - |
Dividend Yield | 4.08% | 7.68% | - | - | - | - |
Payout Ratio | 130.28% | 68.84% | 73.01% | 73.10% | 89.98% | 58.69% |
Buyback Yield / Dilution | -49.34% | -12.05% | 5.09% | - | -44.15% | -44.01% |
Total Shareholder Return | -45.26% | -4.36% | 5.09% | - | -44.15% | -44.01% |